CSE:PHRX - Post Discussion
Pharmadrug Inc
> NEWS: PharmaDrug’s Sairiyo Therapeutics Announces ....
Post by
RBLComm on Oct 31, 2024 4:35pm
NEWS: PharmaDrug’s Sairiyo Therapeutics Announces ....
PharmaDrug’s Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases READ MORE
Be the first to comment on this post